Table 2. Prevalence of adolescent use of any and specific opioid drugs (N = 18686).
| NMPOU | Past-month NMPOU |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lifetime NMPOU (N = 18686) |
Past-year NMPOU (N = 18686) |
Total (N = 18686) |
Without poor sleep (n = 15325) |
With poor sleep (n = 3361) |
||||||
| n | % | n | % | n | % | n | % | n | % | |
| Any NMPOU* | 2719 | 14.6 | 854 | 4.6 | 519 | 2.8 | 377 | 2.5 | 142 | 4.2 |
| Licorice tablets with morphine* | 1705 | 9.1 | 467 | 2.5 | 283 | 1.5 | 201 | 1.3 | 82 | 2.4 |
| Cough syrup with codeine* | 1324 | 7.1 | 412 | 2.2 | 244 | 1.3 | 173 | 1.1 | 71 | 2.1 |
| Percocet* | 1010 | 5.4 | 329 | 1.8 | 205 | 1.1 | 135 | 0.9 | 70 | 2.1 |
| Diphenoxylate* | 198 | 1.1 | 69 | 0.4 | 59 | 0.3 | 35 | 0.2 | 24 | 0.7 |
| Tramadol* | 134 | 0.7 | 75 | 0.4 | 46 | 0.2 | 27 | 0.2 | 19 | 0.6 |
Note: Chi-square tests were used to compare the prevalence of past-month NMPOU between subjects with and without poor sleep.
*p<0.001
NMPOU, nonmedical prescription opioid use.